Greg, there are no proper studies or advanced clinical trials to validate this cancer treatment called Next Generation PDT the Cho Group have commercialised. PDT ( Photo Dynamic Therapy) has been around for years but only seems to have approval here for benign basel cell skin cancers and as a possible last resort option ( UK). The Cho Group appear to have there own new photosensitising agent and are targeting countries with lower regulatory requirements like China, India, Sth Africa.
I just hope that when in Invions press statement Greg Collier says ' we are looking to identify new assets to bring into the company's pipeline' , that this so called Next Generation PDT is not one of them.
IVX Price at posting:
0.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)